FDA Adverse Event Injury Summary report: N

EMBOSPHERE®

MDR report key: 23851847 · Received December 19, 2025

Report

Report Number
1721504-2025-00770
Event Type
Injury
Date Received
December 19, 2025
Date of Event
December 2, 2024
Report Date
December 19, 2025
Manufacturer
BIOSPHERE MEDICAL, S.A.
Product Code
HCG
UDI-DI
00884450402948
PMA / PMN Number
K181300
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE SUSPECT DEVICE WAS NOT RETURNED FOR EVALUATION. THE COMPLAINT COULD NOT BE CONFIRMED. THE ROOT CAUSE COULD NOT BE DETERMINED. A REVIEW OF THE DEVICE HISTORY AND COMPLAINT DATABASE COULD NOT BE PERFORMED SINCE THE LOT NUMBER WAS NOT PROVIDED. NONCONFORMANCES OF THIS NATURE ARE MONITORED BY THE OPERATION TEAM. THIS COMPLAINT WILL BE USED TO TREND FOR SIMILAR COMPLAINTS.

Description of Event or Problem · 0

A LITERATURE ARTICLE REPORTED THAT DURING INJECTION OF THE EMBOSPHERE MICROSPHERES, THE PATIENT DEVELOPED SEVERE THORACIC AND ABDOMINAL PAIN WITH EACH INJECTION. WITHIN APPROXIMATELY 30 MINUTES AFTER THE PROCEDURE, THE PATIENT DEVELOPED ORTHOPNEA, CONFUSION, AND AGITATION. LABORATORY TESTS SHOWED MARKED ELEVATIONS IN HIGH-SENSITIVITY TROPONIN, MYOGLOBIN, CREATINE KINASE, AND CK-MB, CONSISTENT WITH AN ACUTE MYOCARDIAL INFARCTION. BRAIN MRI REVEALED NUMEROUS BILATERAL ACUTE INFARCTS IN THE CEREBRAL HEMISPHERES AND BASAL GANGLIA, CONSISTENT WITH PARADOXICAL CEREBRAL EMBOLIZATION. NO DEVICE MALFUNCTION IDENTIFIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
259106 EMBOSPHERE® EMBOLIZATION PARTICLE, NON-BIOABSORBABLE HCG BIOSPHERE MEDICAL, S.A. 00884450402948

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention